title: MIA, a novel serum marker for progression of malignant melanoma.
abstract: MIA was isolated previously as a small soluble protein secreted from malignant melanoma cell lines in vitro. Highly restricted expression patterns in melanocytic tumors were identified in vivo. We therefore quantitated serum levels of MIA protein by means of a non-radioactive ELISA and investigated whether MIA provides clinically relevant parameters in patients with malignant melanomas. Here we report enhanced MIA serum levels in 13% and 23% of patients with stage I and II disease, respectively, and in 100% with stage III or IV disease. Response to therapy in stage IV disease correlated with changes in MIA serum levels and surgical removal of metastases led to normalization of serum values. Repeated measuring of sera from 350 patients with a history of stage I or II melanoma during follow-up, we detected 32 patients developing positive MIA values. At the time of serum analysis 15 of them had developed metastases and one presented with metastatic disease 6 months later. In conclusion, MIA represents a novel serum marker for systemic malignant melanoma revealing the highest sensitivity and specificity among currently available markers.
authors.affiliation: Department of Pathology, University of Regensburg Medical School, Germany.
authors.forename: A K
authors.initials: AK
authors.lastname: Bosserhoff
authors.forename: M
authors.initials: M
authors.lastname: Lederer
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
authors.forename: R
authors.initials: R
authors.lastname: Hein
authors.forename: W
authors.initials: W
authors.lastname: Stolz
authors.forename: R
authors.initials: R
authors.lastname: Apfel
authors.forename: U
authors.initials: U
authors.lastname: Bogdahn
authors.forename: R
authors.initials: R
authors.lastname: Buettner
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood; D003937:Diagnosis, Differential; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D016326:Extracellular Matrix Proteins; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008545:Melanoma / Q000097:blood* / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D009367:Neoplasm Staging; D009369:Neoplasms / Q000097:blood; D010051:Ovarian Neoplasms / Q000097:blood; D010190:Pancreatic Neoplasms / Q000097:blood; D012016:Reference Values; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D016326:Extracellular Matrix Proteins; C090059:MIA protein, human; D009363:Neoplasm Proteins